Pregnancy in patients with chronic myeloid leukemia treated with imatinib

Leukemia and Lymphoma

Volumn 48, Issue 12, 2007, Pages 2454-2456

  Yilmaz, Mehmet ^a   Demirhan, Osman ^b   Kuçukosmanoglu, Ercan ^a   Pehlivan, Mustafa ^a   Okan, Vahap ^a   Balat, Ozcan ^a   Pehlivan, Sacide ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; IMATINIB;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FUSION GENE; GENETIC VARIABILITY; HUMAN; INFANT; PHYSICAL EXAMINATION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RADIODIAGNOSIS; SPLENOMEGALY; TREATMENT REFUSAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PYRIMIDINES;

EID: 37149023479     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701658751     Document Type: Article

References (11)

1. Kantarjian, H. M., Cortes, J. E., O'Brien, S., Giles, F., Manero, G Garcia and Faderi, S. (2003) Imatinib therapy in newly diagnosed patients with Philedelphia chromosome positive chronic myelogenous leukemia. High incidence of early complete and major cytogenetic responses. Blood, 101, pp. 97-100.
2. Hensley, M. I. and Ford, J. M. (2003) Imatinib treatment: Specific issues related to safety, fertility and pregnancy. Semin Hematol, 40, pp. 21-25.
3. Bazarbashi, M. S., Smith, M. R., Karanes, C., Zilenski, I. and Bishop, C. R. (1991) Succesful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy. Am J Hematol, 38, pp. 235-237.
4. Celiloǧlu, M., Altinyurt, S. and Under, B. (2000) Hydroxyurea treatment for chronic myeloid leukemia during pregnancy. Acta Obstet Gynecol Scand, 79, pp. 803-804.
5. Bear, M. R., Ozer, H. and Foon, K. A. (1992) Interferon-α therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia. Br J Hematol, 81, pp. 167-169.
6. Pharma, A G Novartis (2004) Glivec-Clinical Monograph, Novartis Pharma AG, Basel
7. Heartin, E., Walkinshaw, S. and Clark, E. R. (2004) Succesful outcome of pregnancy in chronic myeloid leukemia treated with imatinib. Leuk Lymphoma, 45, pp. 1307-1308.
8. Ault, P., Kantarjian, H., O'Brien, S., Faderl, S., Beran, M. and Rios, M. B. (2006) Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol, 24, pp. 1204-1208.
9. Suppiah, R. and Kalaycio, M. (2006) Succesful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester. Leuk Lymphoma, 47, pp. 1149-1150.
10. Ali, R., Ozkalemkas, F., Ozcelik, T., Ozkocaman, V., Ozan, U. and Kimya, Y. (2005) Pregnancy under treatment of imatinib and succesful labor in a patient with chronic myelogenous leukemia(CML): Outcome of discontinuation of imatinib therapy after achieving a molecular remission. Leuk Res, 29, pp. 971-973.
11. Alkindi, S., Dennison, D. and Pathare, A. (2005) Imatinib in pregnancy. Eur J Haematol, 74, pp. 535-537.